Cargando…
Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic
Autores principales: | Meca-Lallana, Virginia, Aguirre, Clara, Cardeñoso, Laura, Alarcon, Teresa, Figuerola-Tejerina, Angels, del Río, Beatriz, Álvarez, Miguel Ruiz, Vivancos, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264931/ https://www.ncbi.nlm.nih.gov/pubmed/32544863 http://dx.doi.org/10.1016/j.msard.2020.102244 |
Ejemplares similares
-
COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
por: Meca-Lallana, Virginia, et al.
Publicado: (2020) -
Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
por: Aguirre, Clara, et al.
Publicado: (2020) -
Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs
por: Meca-Lallana, Virginia, et al.
Publicado: (2023) -
Cognitive Dysfunctions and Assessments in Multiple Sclerosis
por: Oreja-Guevara, Celia, et al.
Publicado: (2019) -
A New Surgical Site Infection Risk Score: Infection Risk Index in Cardiac Surgery
por: Bustamante-Munguira, Juan, et al.
Publicado: (2019)